SEC Company Response from Medigus Ltd. (XYLO) (CIK 0001618500) — May 13, 2020
Medigus Ltd. (XYLO) (CIK 0001618500)
Date: May 13, 2020 · CIK: 0001618500 · Accession: 0001213900-20-012028
AI Filing Summary & Sentiment
File numbers found in text: 333-238162
Show Raw Text
CORRESP
1
filename1.htm
May 13, 2020
Securities and Exchange Commission
Division of Corporation Finance
100 F Street N.E.
Washington, D.C. 20549
Attention:
Division of Corporation Finance,
Office of Life Sciences
VIA EDGAR
Re:
Medigus Ltd. (the “Company”)
Registration Statement
on Form F-3 (the “Registration Statement”)
Filed on May 11, 2020
File
No. 333-238162
Dear Madam or Sir:
Pursuant to Rule 461
under the Securities Act of 1933, as amended, the Company respectfully requests that the effectiveness of the registration statement
on Form F-3 (File No. 333-238162) of the Company (the “Registration Statement”) be accelerated so that the Company’s
Registration Statement will become effective at 08:30 a.m., Eastern Time, on May 15, 2020 or as soon thereafter as may be practicable.
The undersigned respectfully
requests that it be notified of the effectiveness of the Registration Statement by email to our counsel, Meitar Law Offices, by
emailing Dr. Shachar Hadar, Esq. at shacharh@meitar.com.
Sincerely,
/s/
Liron Carmel
Liron
Carmel
Chief
Executive Officer
Medigus
Ltd.